Agilent Technologies at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Agilent Technologies brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 617. Its sessions cover RNA-based tumor profiling for molecular classification beyond fusion calling, and targeted long-read sequencing applied to hereditary cancer research. The company supplies instruments, consumables and software to diagnostic and life science laboratories.
| Organization | AMP 2026 Attendance |
|---|---|
Agilent Technologies Santa Clara, CA | |
Supplies instruments, consumables, software and services for life science, diagnostics and applied chemical laboratories. | Booth Exhibiting at Booth 617 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm Beyond Fusion Detection: Scalable RNA-Based Tumor Profiling for Molecular Classification RNA sequencing of tumours for fusion detection and expression-based classification, run through automated library prep. Workshop Fri, Nov 13 12:40pm–1:10pm Resolving the Unresolvable: Targeted Long-Read Sequencing for Hereditary Cancer Research Targeted long-read sequencing for hereditary cancer genes, covering capture panel design, sample prep and results in repetitive regions. |
Instantly find 20 buyers from Agilent Technologies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction